Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New clinical affairs VP for WorldHeart

This article was originally published in RAJ Devices

Executive Summary

Monica Hope has joined WorldHeart, a US-based developer of mechanical circulatory systems, as vice president of clinical affairs. Dr Hope will be responsible for conducting current and future clinical trials of WorldHeart's products. Dr Hope was previously director of clinical affairs at Second Sight Medical Products, a privately held US firm that is developing a retinal prosthesis for patients blinded by outer retinal degeneration. Salt Lake City, Utah-based WorldHeart is developing a ventricular device, Levacor, which it claims is the only fully magnetically levitated, bearingless, implantable centrifugal pump to move into clinical trials.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts